Lebenthal Global Advisors’s Alkermes ALKS Stock Holding History

Lebenthal Global Advisors’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-250	Closed	-$4K	–	148
2020 Q4	$4K	Buy	+250	New	+$4.58K	﹤0.01%	500

Other funds holding ALKS

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Lebenthal Global Advisors's ALKS Position: Q1 2021 in Review

Lebenthal Global Advisors sold out of Alkermes (ALKS) in Q1 2021, closing a stake of 250 shares — an estimated $4K sold.

Lebenthal Global Advisors first reported a position in ALKS in Q4 2020 and held it in 1 quarter. The position peaked at $4K in Q4 2020. 200 funds tracked by Wall St. Rank hold ALKS as of Q1 2021.

Lebenthal Global Advisors reported no remaining Alkermes position as of Q1 2021 after selling out during the quarter.
Lebenthal Global Advisors sold 250 Alkermes shares in Q1 2021, an estimated $4K.
Lebenthal Global Advisors first reported a position in Alkermes in Q4 2020 and held it in 1 quarter.
Lebenthal Global Advisors's Alkermes position peaked at $4K in Q4 2020.
200 funds tracked by Wall St. Rank held Alkermes as of Q1 2021.

Based on Lebenthal Global Advisors's 13F filing for Q1 2021, filed 7 May 2021.